ResearcherFirst Hospital of Lanzhou UniversityActive in the last 2 years
Chunlu Dong
Matched on OpenAlex author ID A5100963647. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 4
- Knockdown of PPP2R2B inhibits pancreatic cancer progression via the ERK/MAPK pathway by modulating EMT and apoptosis Co-author DOI 10.21203/rs.3.rs-5324510/v2↗
- Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic cancer and is associated with B-cell Infilt… Co-author DOI 10.3389/fonc.2024.1283164↗
- Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells. Co-author DOI 10.36721/pjps.2024.37.2.reg.327-336.1↗
- miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis. Co-author DOI 10.1111/jcmm.16405↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fangfang Han · 3 shared papers, 2024–2025 · strength 0.70
- Paper Knockdown of PPP2R2B inhibits pancreatic cancer progression via the ERK/MAPK pathway by modulating EMT and apoptosis DOI 10.21203/rs.3.rs-5324510/v2↗
- Paper Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells. DOI 10.36721/pjps.2024.37.2.reg.327-336.1↗
- Paper Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic can… DOI 10.3389/fonc.2024.1283164↗
- Huaqing Shi · 2 shared papers, 2024–2025 · strength 0.51
- Yan Du · 2 shared papers, 2024–2025 · strength 0.51
- Wence Zhou · 2 shared papers, 2021–2024 · strength 0.38
- Wence Zhou · 1 shared paper, 2025 · strength 0.27
- Zhou Chen · 1 shared paper, 2025 · strength 0.27
- Shi Dong · 1 shared paper, 2024 · strength 0.24
- Wence Zhou · 1 shared paper, 2024 · strength 0.20
- Chen Zhou · 1 shared paper, 2024 · strength 0.20
- Hui Zhang · 1 shared paper, 2021 · strength 0.14
- Hao Xu · 1 shared paper, 2021 · strength 0.14
- Zhengfeng Wang · 1 shared paper, 2021 · strength 0.14
- Xin Li · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.